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Previous studies of loss of heterozygosity (LOH) have 
revealed distinct patterns of allelic loss in some skin 
tumors. In basal cell carcinomas (BCCs) loss of het-
erozygosity is virtually restricted to chromosome 9, 
w hereas in squamous cell carcinomas (SCCs) and 
actinic keratoses loss is more widespread involving 
chromosomes 3, 9, 13, and 17. Because there are 
histological similarities between BCCs and some ap-
pendageal tumors, and because some lines of evi-
dence suggest that BCCs are appendageal in origin, 
we carried out a limited allelotype in 41 appendageal 
tumors. The overall frequency of allelic loss was low 
(4 out of247 informative loci; 1.6%). LOH was seen in 
C lIlTent models of human carcinogenesis emphasize the causal relation between the accumulation of genetic abnormalities and the clin ica l behavior of a n eoplasm (Yokota and Sugimura, 1993) . Probably the best exampl e is colorectal can cer where work by 
Vogelstein and othe rs (Fearon and Vogelstein, 1990) has shown 
that the stages of tumor progression as defined histopathologically 
correlate with th e accumu lation of abnormalities in oncogenes and 
tumor suppressor genes. A lthough oncogenes were the first genes 
identified in human cancer, and therefore earlier work focused on 
their characterization , recent attention has cente red on the ro le o f 
rumor suppressor genes in human n eoplasia (Ponder 1988; Sager, 
1989 ; Fearon and Vogelstein, 1990; Yokota and Sugimura, 1993). 
Evidence implica ting tum o r suppressor genes in C'lI1cer pathogen-
esis comes from a number of sources. First, cell fusion studies 
between normal and malignant cells suggested that certain chro-
mosom es possessed tumor suppressing activity, and that this char-
acteristic was recessive (Ande rson and Stanbt;dge, 1993 ). Second, 
based on observations of the epidemiology of retinoblastoma , 
Knudson (1971) proposed that some inherited hum an m alignan cies 
may be due to an inherited mu tation in one copy of a tumor 
suppressor followed by a second hit to the other allele. This 
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a proliferating trichilemmal cyst (17p), a sebaceous 
epithelioma (17q), an eccrine porocarcinoma (17q), a 
trichoepithelioma (9q), and in two basal cell carcino-
mas showing eccrine or granular cell differentiation 
that were originally misdiagnosed (9q). The pattern 
of loss in this mixed group of appendageal tumors 
shows differences from both BCCs and SCCs, and 
further emphasizes the unique genetic profile and 
behavior ofBCCs. The finding of9q loss in BCCs with 
eccrine or granular cell differentiation shows that 9q 
loss occurs in different histological subtypes ofBCCs. 
Key 1II01'ds: t,,"'OI' s"ppl'essol' gene/basal cell cal'cil/.omaJ 
miCl'osatellites/p53.j II/vest D e"lIIatol106:1141-1144, 1996 
hypo thesis suggested that similar (recessive) genes m ay be involved 
in inheri ted and sporadic ca ncers. Subsequent work has vindica ted 
this hypothesis for a number of different tWll or rypes (Ponder, 
1988) . It is of interest to cutan eous bio logists that the germ of this 
idea as applied to m ouse skin can cers was orig in ally suggested ill the 
1940s (Chades and Luce- C lausen, 1942). 
In epithelial neoplasms , de fects in putative tumor suppressor 
genes seem esp ecially comm on and o utnumber the oncogenes 
implicated in th ese cancers (Fearon and Vogelstein , 1990; Yokota 
and Sugimura, 1993). T his m ay in part relate to the technical 
strategies adopted to ide nti fY new ca ncer-ca using genes (Ponder. 
1988; Sager, 1989). Although tumor suppressor genes may be 
inactiva ted in a number of difFerent ways, including binding to viral 
proteins o r products of other genes (Lan e, 1994) , a particularly 
commo n mechanism is mutation of o ne alle le followed by loss of 
the rem aining allele (Po nder, 1988; Sager, 1989). T his deletion of 
genetic m ate rial results in loss of heterozygosity (LOH) w hen 
alleles are examined using polYl1101'phic m arkers, m aking it possible 
to screen chromoso m al areas of interest using polym e rase hain 
reaction LOH-based assays. 
Examinatio n of the pattem of allele loss across aU the autosomes 
in tumors from difFeren t o rgans sho ws that although there are many 
similarities, perhaps reflecting the importan t cellular fu nction of 
certain key genes such as p53 and retinoblastom a in skin, there aTe 
clear difFerences between basal cell and squamous cell carcinomas 
(Quinn et ai, 1994a; R ees, 1994). Squamous cel.l carcino m as (SCCs) 
show a high frequency of allele loss at a number of loci including 
3p, 9p, 9q, 13 , and 17p (Quinn c ( ai, 19943). By contras t, and 
uniquely among human epi thelial cance rs that freque ntly undergo 
p53 mutatio n (van der Rict Ci ai, 1994) . the majority of 
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Table I. Low Frequency of Loss of Heterozygosity At Selected Loci in Cutaneous Appendageal Tumors" 
ChrOlllOSOll1C Arl11h 
Tlllllor (Number) Ig 3p 9p 9g 13g 17p 17g 19q 
Eccrine poroma (7) 0/7 0/7 0/4 0/6 0/7 0/6 0/3 0/ -1 
Piiol113tricolna (5) 0/5 0/5 0/4 0/4 0/4 0/ 4 0/ 5 0/ -1 
Trichilcmmoma y (2) 0/1 012 012 0/1 012 0/1 0/ 1 0/ 1 
Trichoepithelioma (1) ND" ND 0/1 1/1 ND ND ND 0/0 
Clear cell hydroadcnoma (4) 0/3 013 0/3 0/2 013 ul3 0/4 0/3 
Eccrine spiradcnoma (3) 0/2 0/1 0/1 0/2 0/2 0/2 0/ '1 al l 
Cylindroma" (12) 017 0/9 a/ II 0/12 0/9 0/9 0/ 9 0/ 
Acrosyringca l nevus (I) 0/1 all all all Oil 0/1 0/ 1 a/ I 
Apocrine cystadenoma (I) 0/1 0/1 0/0 0/ 1 0/1 0/ 1 ND 0/ 1 
Apocrine ductadenOl11i1 (I) 0/1 0/1 all 0/1 0/1 0/0 0/1 0/ 1 
Proliferating trichilemmal cyst (1) 0/1 0/1 0/1 0/0 Oil I II 0/ 1 Oil 
5ebaceous epithelioma (1 ) all all 0/:1 0/0 0/1 0/ '1 111 0/0 
nce' (2) 0/2 012 0/2 2/2 0/2 012 012 0/2 
Eccrine porocarcinoma (1) 0/1 Oil 0/1 0/0 0/1 0/1 1/1 DID 
Merkel ce ll carcinoma (I) a/I a/I 0/1 a/I 0/1 0/1 Oil ala 
,/ N umber of tumors showing loss of heterozygosity/ number of tumors inlofm:lti vl!. 
II Microsaw llitc markers lIsed arc given in the text. 
(" Not done. 
d ObUlincd frol11 three paticlHs. two of which from the same kindred of dermal cylindromarosis . 
.. Granular cell BeC (20) and DeC showing eccrin e dillcrc.l1tiation (2 1). 
deletions that occur in b asa l ce ll carcin oma center around one 
particular locus, the nevoid basa l ce ll carcinoma syndrome locus 
(NBCCS) at 9q22-31 (Gail ani cl nl, 1992; Quinn c( nl, 1994b; van 
der Riet e/ (//, 1994). Although it is tempting to expect differences 
between BCCs and SCCs becanse SCCs may behave m ore aggres-
sively, preinvasive lesion s such as actinic keratoses sh ow a rate of 
allelic loss similar to, if no t higher than that ofSCCs (Rehman e( nl, 
1994). I t i,< for these re"sons thM w e studied the pattern of aIJ e li c 
loss in appendageal t umors. Many of these tumors show histological 
similarities to, and overlap clinically with BCCs (Lever, 1948a; 
Lever and Schaumburg-Lever, 1990). Conversely , there is evidence 
that BCCs may be derived from the adn exal structures (Lever, 
1948b; Pinkus, 1953). We were therefore inte rested to see whether 
the pattern of allele loss in appendage tumors would resemble that 
seen in BCCs or other cutaneou s neoplasm s such as SCCs. 
MATERJAL5 ANO METHODS 
Forty-three tumors fro m 34 patients with a primary pathological diagnosis 
of any appendagea l tumor were retrieved from the pathology files of 
Kanazawa University Hospital. Japan, and the Royal Victoria Infirmary. 
Newcastle, UK. Subsequently, hematoxlin alld eosin-st"ined slides of aU the 
tumors were reviewed independently by two expert dermatopathologists 
(M.T. and K.H.) without knowledge of the LOH data, and a revised 
pathological diagnosis was made for each tumor. Two patients [rom the 
same kindred presented with multiple cylindromas and eccrine spiradeno-
nlas. 
After a representative paraffin block WaS selected for cach tumor, 15-J-Lm 
sec tions were cut , dewaxcd. and microdissccted o n an inverted rni c roscape . 
TUlllor DNA and corresponding normal DNA was iso lated by proteinase K 
digestion and phenol-chloroform extraction Uackson ci ai, 1992) , In sOl11e 
cases , tumor DNA were directly isolated from snap-frozen samples and 
control DNA was obtained from venous blood. Analysis of LOH was 
carried out by polymerase chain reaction ampl ifi cation of microsateIJite 
polymorph isms as described previously (Quinn el (/1, 1994a,b). Briefly, 
polymerase chain reaction was performed with "pproximate/y 100 ng of 
template DNA with 200 mM deoxynuclcotide triphosphates, 1 pmol of 
each oligonucleotide primer, one of whkh was end-labeled with 
[y_J2 PjATP, and I unit of Tnq DNA polymerase (Biotag; lliobne, UK). 
Amplification consisted of 30 cycles of I min at 95°C , 1 min at 55°C , and 
I min 72°C with a final la-min extension at 72°C, The microsatcllite 
oljgonucleotide primers used were DI S212 (1 q) , 0351293 (3p), D95162 
(9p), D9S171 (9p), D9S176 (9q), D95197 (9g) , D9S160 (9g), IJ13S 170 
(13q), 0175796 (171') , DI75785 (17g), and 0195255 (19g) . all obta ined 
from R.csearch Genetics (Huntsvill e, AL), Polymerase chain reaction prod-
ucts were separated by electrophoresis through 6'Y.. acrylamjdc gels. Because 
suffi cient ONA was available from the two tumors showing 9q loss, detail ed 
deletion mapping on chromosome 9 as well as a allclotype of all 39 
autaS0l11C anTIS we re carried Ollt far these two tumors ll sing the fo llowing 
markers: D95162, 095171, 095169, D95161, 095163 (9p) , D9S1 65. 
D9S166. 1J9S152, 09S197, D9S180, D9S173, D9S176, 095172 , D951 60, 
D9S174,D9S158 (9g), D IS20l (11')' D I5304, 015212 (lq), 02S1 66. 
025149 (2p), D2S163 , (2g), 0351268 (3g) , 045394 (4p), 045402 (4q), 
05S419 (5p), 1J5S410 (5g). D6S299 (6p), D6S262 (Gg), 1J7S481 (7p), 
075495 (7q), 085261 (8p) , 085257 (8g) , D10S226 (lOp), 01051 85 (l Oq), 
DIIS922 (llp), 011S910 (1 Ig), D12S98 ('I2p) , 012S86 (12q), 014S73 
(14g) , 1J15S1 18 (1Sg) , D16S4 14 (lGp), 1J165422 (16g) , D l 8S59 (1 8p) . 
DI8570 ( 18g) , 01952 16 (19p), 0205104 (20p), D20SIOO (20g) D21S262 
(21 g) , and D22S283 (22g). 
RESULTS 
Histopathological re-review on hematoxlin and eosin sections 
identified 39 benign appendageal tumors (seven eccrine poromas, 
five pi.lomatricomas, two trichiJemmomas, o n e trichoepithelioma, 
four clear cell hidradenomas, three eccrine sp iradenomas, 12 
cylindromas, one acrosyringeal nevus/eccrine syringofibroad-
enoma, one appocrine cystadenoma, one appocrine ductadenoma, 
one proliferating trichilemmal cyst, one sebaceous epithelioma), 
two BCC variants (one g ranular ce ll BCC (Barr and Graham, 1979) 
and one BCC with eccrine differentiation (Freeman and Winkel-
m ann, 1969», and two appendageal carcinomas (one eccrine 
porocarcinoma and one Merkel cell carcinoma) (Table I) . The two 
his tologica l variants of BCCs were included in this study because 
their original pathological diagnosis h ad been trich.iJemmoma and 
clear cell hidradenoma, respectively, and because examination of 
the pattern of a llele loss in these types of BCC has not been 
reported before. 
T h e overall frequency of LOH o n th e e ig ht ch.romosome arms 
examined was low with only 4 of 41 tumors showing loss (exclud-
ing th e two BCCs). N o appendage tumors showed loss at m ore 
than o n e locus (Table I). The rare variants of BCC (granular cell 
BCC and BCC Witll eccrin e differentiation), and one trichoepithe-
lio m a sh owed LOH of chromosome arm 9q w ith the retention of 
9p. Full allelotype analyses and the detailed deletion mapping of 
chromosome 9 were carried o ut for these two BCC variants . In th e 
granular cell BCC, 30 out of 39 chromosome arms were iuforma-
tive and allelic loss was only seen for loci on 9q and 4q. D ele tion 
mapping of chromosome 9 revealed a deleted region te lomeric to 
D9S166 iJlc1uding D9S197, D9S180, D9S176, and D9S160. 111 the 
BCC with eccrine differentiation, no a lle li c loss except for chro-
mosome 9q was identified fo r 35 informative chromosome <Inns. 
Deletion mapping of chromosome 9 for this tumor showed reten-
tion of D9S152 which lies between 9q13 and 9q22.1 and loss of 
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Figure 1. Loss of h eterozygosity analysis in appendageal tumors 
using rnicrosatellitc polymorphism D17S785 (17q). Polyme rase chain 
reaction products from normal (N) and tumor (7) DNA. Allelic losses are 
seen in an eccrine porocarcinoma (TJ) and a sebaceous epithelioma (TJ). 
Two piJomatricomas (T2 and T4) show 110 loss. 
D9S197, which is a proximal flanking marker for the BCCNS locus 
(Goldstein cf ai , J 994), as well as loss of D9S173. Unfortunate ly, 
these analyses could not be carried out for the trichoe pithe lioma 
because of lack of sufficient tumor DNA. 
Isolated loss of chromosome arm 17q with retention of 17p was 
observed in a sebaceous epithelioma and an eccl;ne porocarcinoma 
(Fig 1). A proliferating tri chj lemmal cyst showed isolated 17p loss. 
No allelic loss was identified in the one case of Merkel ce ll 
carcinoma . In view of the reported assoc iation between pilomatri-
coma and myotonic dystrophy (Chia ramonti alld Gilgor. 1978) 
(which maps to chromosome 19q (Smeets cf ai, 1991», the 
frequency of LOH at D19S255 was in vestigated in pilomatricomas 
and other cutaneous appendagea l tumors. None of the 27 informa-
tive tumors, including four pilomatricomas, sh owed allelic loss. 
DISCUSSION 
We have examined 41 appendageal tumors for LOB at loci on 
chrotTIosom e arms implicated in either BCCs or SCCs (Gai lani cf ai , 
1992; Quinn cf ai, 1994a), and on chromosome 19q (Smeets ef ai, 
1991) because of the reported association between pilomatricomas 
and myotonic dystrophy (Chiaramonti and Gilgor, 1978). We 
found LOH to be uncommo n: o ne trichoep ithe lioma showed 9q 
loss (but see below); o ne p ro li ferating trichi lemmal cyst showed 
loss of 17p; both a sebaceous epithelioma and an eccrine porocar-
cinoma showed loss of 17q. III interpreting the resu lts there are a 
nmnber of factors that need to be considered. First, although 
samples were microdi ssected frol11 visible contaminating tissue, it is 
impossible to exclude in all cases that LOH may have been mjssed 
because of the presence of nontumor cells. Similar studies on 
equally small les ions where LOH was detected (Quinn cf ai, "I 994a; 
Rehman et ai, 1994), however, suggest that this is unlike ly to have 
been a major proble m. Second, the finding of LOB, without 
further fimctiona l experiments in the appropriate cells, does not 
prove the presence of an unde rlying tumor suppressor gene (Sager. 
1989). A ltematively, inactivation of a tumor suppressor gene may 
have occurred by other mech anisms such as point mutation (Fearon 
and Vogelstein, 1990). Small de letions are likely to have been 
missed by the present study. 
BCCs are unusual both in terms of their cli.ucal behavior and 
their gene tics. Clinically, w lu le they may be quite indolent and 
rarely metastas ize, they are invasive and locally destructive (Mi ller, 
1991). Their genetics is unusua l because, unlike many other 
epirhelial tumors which show fj 'equent p53 mutations, they rarely 
show allelic loss, with the exception of the chromosome 9, which 
harbors the NBCCS locus (Gailani ef ai , 1992; Quinn et ai, 1994a,b; 
Rees, 1994; R ehman cf ai , 1994; van der Riet cf ai , 1994). Loss 
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encompassing thjs locus occurs in up to 70% of sporadic tumo rs 
(Quinn ef ai, 1994a) . Various Lines of evidence suggest that BCCs 
may be appendagea l in origin (Lever, 1.948b; Pinkus, 1953), and 
because of both clinical and hjstological overlap between BCCs and 
som e adnexal tumors (Lever, 1948a; Lever and Schaumburg-Lever, 
1990), w e were in terested to examine whether the loss of the 
NBCCS locus occurred in adnexal tumors. Any similariti es be-
tween appendageal tumors and BCC might reAect a number of 
different mechanisms . For instance, if different tumor types are 
derived from a common normal progenitor cells , then the pathways 
of aberrant differen tiation leading to neoplasia may show simjlari-
ties. Second, appendageal tumors and BCCs might share an early 
common neoplastic stage before the ir pathways diverge, and third, 
irrespective of their cellular origins. loss of the NBCCS locus might 
restrict the subsequent phenotype of an epiderm al keratinocyte 
tumor. 
Using marke rs that are close to the NBCCS locus (Goldstein ef ai, 
1994; Wicking ef ai, 1994) and arc known to be deleted at high 
freq uency in sporadic BCCs (Quinn ef ai, 1994b; van del: Riet et ai, 
1994), allele loss was initially only seen in three of the tumors we 
screened . Deletion m apping in these cases showed that the inter-
stitial deletions were cen tered around the NBCCS locus (Goldstejn 
ef ai, 1994; Wickillg ef ai , ] 994). Subsequent to the molecular 
analysis, however, expert pathologica.! review of two of these cases 
suggested that they were in fact BCCs with either gran ular cell 
(Barr and Gra ham , 1979) or eccrine cell djfferentiation (Freeman 
and Winkelmann, 1969) respectively, rather than a trichilemmoma 
and a clear cell hidradenoma . T he remruning case, that of a 
trichoepithe lioma that showed loss at the NBCCS locus. should be 
interpreted carefully. Thjs was a solitary trichoepithelio ma excised 
from a patient who had received treatment for multip le BCCs. As 
the differentiatio n of trichoepithelioma from keratotic BCC on 
lustological grounds alone is ve ry difficu lt or even impossible 
(Lever and Lever-Schaumburg, 1990), we cannot excl ude the 
possibi ljry that the tUlllor was no t a trichoepithelioma. It is worth 
noting that an association between trichoepithe liomas and BCCs 
has been reported in patients with Bazex syndrome (Bazex ef ai , 
1966) (which maps to Xq24-q27 (Vabres ct ai, 1995» and the 
Rombo syndrom e (Michaelsson e/ ai , 1981). T he almost comp lete 
absence ofloss of9q in appendageal tUlllors suggests a clear genetic 
difference from BCCs. It is not, however. very helpful in further 
examining the relation between appendageal and basal cell carci-
nom a origins. Given that the two tumor types arc often sim ilar in 
size, if the tumors do share a common early stage, then loss of 9q 
must occur after their pathways of differentiation have separated . It 
is inte resting to note that the two histological variants of BCCs 
acc identa lly included in th is study showed LOB of chromosom e 
9q. Full allelorype and fine deletion m apping of chro moso m e 9 in 
these tumors revea led that LOH was restricted to chromosome 9q 
with thc de leted area en compassing the NBCCS locus (Goldstein ef 
ai , 1994; W ickin g ef al . 1994) . This result clearly iJldicates that these 
two cases of BCC variant have the same characteristic genetic 
chan ge of ordinary BCCs (Gailani cf ai, 1992; QuiJ1I1 ef al. 1994a,b: 
R ees, 1994; van del' Rie t ef ai, 1994). Previous studies have not 
examined the relationship between hjstological type and the pattem 
of gen etic changes iJl BCCs (Gajlanj ef aI, 1992: Qujnn cf ai , 
1994a,b; Rees, 1994; van der l:tiet ef ai, 1994), and our result 
suggests that chromosom e 9q loss occurs i.n a variety of difFerent 
hjstological types of BCe. 
Derma l cylindromatosis is an autosomal dominant d isorder, and 
recent genetic linkage analysis reported the localization of the gene 
to chromosome 9p 12-13 between D9S161 and interferon gene 
clustcr (Wooster R., Mangion J, Qu irk Y. Ford D, Easton DF, 
C hapman P. Bum J, Weaver-Feldhaus J, Kamb A, Ponder BAJ. 
Stratton MR: Localization of the gene for cylindromatosis (turban 
tumor syndrome) to chro mosome 9p12-13. Alii J HI/III Gwef 
55(Suppl):A207, 1994, abstr.). All of the tumors excised from o ur 
two patients belonging to the same kindred of this disorder, 
however, d id not show LOB for 9p m arkers D9S162 and D9S171, 
although these two microsatelli te markers locate slig htly te lo m e.;c 
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to th e reported gene locus. Trichoepitheliomas and eccrine spi ra-
denomas are commonly associated w ith d ermal cyli ndrom atosis 
(We lch e( (/1, 1968; Rasmussen , 1.969) , but n o loss of chrom osome 
9p was o bserved in the trichoep ithe li oma and four eccrin e spirade-
nomas exa mined . T he absence of LOH at this locus does not 
exclude an underlying predisposition gene, however, as n ot all 
inh erited ca ncer-causin g gen es are accompanied by LOH in the 
primary tumors (Ponder, 1.988; Fearon and Vogelstcin , 1990). 
T he finding o f LOB fo r 17q in a sebaceo us epithelio m a and an 
eccrine po rocarcinoma , and loss of 17p in a proliferating trichilem-
mal cyst dem o nstrates that th e les io ns are c10nally derived (other-
wise one would not see c1e,l r evide nce of LOH). C hromosome 17 
harbo rs a numbe r of ca ndidate tumor supp ressor genes including 
BRCA 1 (17q) (Hall c( ai , 1992) and p53 (17p) (Nigro ef ai, 1989), 
and loss of 17p and 17q is freq uently seen in SCCs (Quinn ct ai, 
1994a) . With respect to the proliferating trichilemmal cys t, suffi-
c ient DNA was avai lable to allow seq uen cing of the p53 gene, 
w hi ch showed a missen ce mutation in exon 8: this sugges ts that in 
this part icular in stance p53 was tbe targe t tumor suppressor gene o n 
chromosome 17, although othe rs ma y be involved (Wales ct (/1, 
1995) . 
A fina l point re lates to the low fi·equen cy ofloss scen at any locus 
in the tumors stud ied. Beca use not all au tosomes were examin ed, it 
is possible th at a lle lic loss may in fact be hig her. T he loci studied 
were ch osen beca use of their freq uen t in volvcment in other forms 
of skin can cer and epithelial m alignan cies. M apping of an y of the 
inherited syndromes in volv ing appendageal tumors to other auto-
somes would inv ite furth er scrutiny of these regions in sporadic 
tumors. T his no twi thstanding, the low rate of all e lic loss is perhaps 
in keepin g with the behavior of m ost of th e neoplasms examul ed . 
Many appen dagea l tumors are clinica lly benign, a lthough it is 
worth noting that this is not true for some of the tumors studied, 
includin g the sebaceous epithelioma, M erkel cell carcinom a, and 
eccrin e poroca rcinom a (Lever and Schaumburg-Lever , 1990) , all of 
w hich showed no or only ITlinimal loss . In other cancer systems, 
earl y les ions w hich are clinically benign may show LOB (LaUe ef (/1, 
1994), and in skin the relation betw een loss and be havior is not 
straightforward, w ith prein vasive lesions such as actinic keratoses 
showin g as hjgh or higher rate o f loss than SCCs (Rehman ef (/1, 
1994). Our results suggest that other explanations and mechanisms 
of aberran t growth con tro l may need to be examined to explain the 
beha vior of these neoplasms. 
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